top of page
Search
  • Writer's pictureirene garcia
    • Jan 3
    • 4 min read

Cancer Profiling Market Size, Growth, and Industry Statistics | Latest Insights till 2030

Market Overview: Global Cancer Profiling Market


According to the latest report from MarkNtel Advisors, the Global Cancer Profiling Market projecting a probable CAGR of approximately 11.5% for the forecast period 2024-2030. The renowned market research firm specializes in evaluating business performance, product portfolios, operational segments, and industry developments. Through a meticulous research process, we furnish stakeholders with accurate market projections and estimates, solidifying its reputation for delivering precise insights into the market landscape.


Additionally, the report delves into comprehensive analyses of emerging trends, competitive landscapes, and potential growth drivers within the Cancer Profiling market. Our commitment to a thorough examination of market dynamics ensures that stakeholders receive invaluable insights, empowering them to make informed decisions and stay ahead in the rapidly evolving business environment.




Growth Prospect of Cancer Profiling Market:


Rising Adoption of Precision Medicine Augmenting Market Growth: Personalized medicines are treatments that are tailored to a patient's unique genetic, environmental, and lifestyle characteristics to deliver targeted & precise therapies. The consumers' growing awareness of personalized medicine's superior efficacy to conventional medicine for cancer treatment has been driving their demand, especially across countries the US, India, the UK, etc.


Insights into The Dominant Segments in The Cancer Profiling Market


Our comprehensive analysis of the Cancer Profiling Market provides valuable insights across various segments, enabling potential investors to make informed decisions for optimal returns. Recognizing the need for a thorough understanding of profitable opportunities, our analysts have meticulously categorized the market into distinct segments, including.


Each segment is further sub-categorized, unlocking extended benefits and facilitating a detailed examination of potential avenues for investment. Our report not only delves into each sub-segment but also highlights the dominant player that has held the largest market share throughout the historical period. This strategic approach equips investors with a comprehensive overview, empowering them to navigate the Cancer Profiling Market with precision and capitalize on the most lucrative opportunities available.



-By Type of Cancer

  • Breast Cancer - Market Size & Forecast 2019-2030, USD Million

  • Colorectal Cancer - Market Size & Forecast 2019-2030, USD Million

  • Gynecological Cancer - Market Size & Forecast 2019-2030, USD Million

  • ‎Leukemia - Market Size & Forecast 2019-2030, USD Million

  • Prostate Cancer - Market Size & Forecast 2019-2030, USD Million

  • Lung Cancer - Market Size & Forecast 2019-2030, USD Million

  • Others (Pancreatic Cancer, Skin Cancer, etc.) - Market Size & Forecast 2019-2030, USD Million

-By Technology

  • Next-Generation Sequencing - Market Size & Forecast 2019-2030, USD Million

  • Polymerase Chain Reaction - Market Size & Forecast 2019-2030, USD Million

  • Mass Spectrometry - Market Size & Forecast 2019-2030, USD Million

  • In-Situ Hybridization - Market Size & Forecast 2019-2030, USD Million

  • Microarrays Analysis - Market Size & Forecast 2019-2030, USD Million

  • Others (Single-Cell Sequencing, etc.) - Market Size & Forecast 2019-2030, USD Million

-By Biomarker Type

  • Genomic Biomarkers- Market Size & Forecast 2019-2030, USD Million

  • Proteomics Biomarkers- Market Size & Forecast 2019-2030, USD Million

  • Others (Epigenetic Biomarkers, Metabolomics Biomarkers, etc.)- Market Size & Forecast 2019-2030, USD Million

-By Cell Type

  • Germline - Market Size & Forecast 2019-2030, USD Million

  • Somatic - Market Size & Forecast 2019-2030, USD Million

-By Application

  • Oncology Research - Market Size & Forecast 2019-2030, USD Million

  • Precision Medicine - Market Size & Forecast 2019-2030, USD Million

  • Clinical Diagnostics - Market Size & Forecast 2019-2030, USD Million

  • Others (Prognosis, Monitoring and Recurrence Detection, etc.) - Market Size & Forecast 2019-2030, USD Million

-By End-User

  • Hospitals and Clinics - Market Size & Forecast 2019-2030, USD Million

  • Research Institutions and Laboratories - Market Size & Forecast 2019-2030, USD Million

  • Diagnostic Service Providers - Market Size & Forecast 2019-2030, USD Million

  • Pharmaceutical and Biotechnology Companies - Market Size & Forecast 2019-2030, USD Million


In addition to such classification, our reports also pinpoint geographical area that either dominate the market in terms of size or volume or exhibit promise for the future. Drawing on demographics, consumer behavior, market supply and demand, and historical market performance, we project the geographical growth of the market across areas such as


-By Region

  • North America

  • South America

  • Europe

  • The Middle East & Africa

  • Asia-Pacific



Prominent Cancer Profiling Market Players and Their Strategic Outlook


The report identifies key players in the market and conducts a comprehensive analysis of their business strategies, trends, innovations, and manufacturing infrastructure to forecast their market presence over the next five years. The meticulously researched data has the potential to set even new entrants apart in the long term. Armed with the right data and actionable insights, our research report offers a holistic view of the market, empowering investors or stakeholders to establish a robust presence in the Cancer Profiling market. The major players featured in the research report, including their net worth and valuation in USD, are


  • NeoGenomics Laboratories

  • Eurofins Genomics GmbH

  • Hoffmann-La Roche Ltd (Foundation Medicine)

  • OncoDNA SA

  • 10x Genomics, Inc.

  • Caris Life Sciences.

  • Genetron Holdings Limited

  • Laboratory Corporation of America Holdings (LabCorp)

  • Dante Labs Inc.

  • Celemics, Inc.

  • Strand Life Sciences

  • Myriad Genetics, Inc.

  • QIAGEN GmbH

  • Tempus Labs

  • Others


Cancer Profiling Market Report Cover User Following Question:


  1. What is the current size and share of the Cancer Profiling Market, and what growth trends are anticipated shortly?

  2. How does the demand for [specific product/service] in the Cancer Profiling Market look, and what factors contribute to its growth or decline according to recent research reports?

  3. What is the forecast for the Cancer Profiling Market in terms of size, growth, and emerging trends over the next few years?

  4. How has the Cancer Profiling Market evolved recently, and what are the latest developments that industry professionals should be aware of?

  5. What key factors contribute to the demand for Cancer Profiling Market, as outlined in the most recent research report?


Our Blogs:



About Us


MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.


Media Representative


Company Name: MarkNtel Advisors

Phone: +1 628 895 8081 + 91 120 4278433

2 views0 comments

Comments

bottom of page